FDA Report Finds No Conclusive Death Links in Children to COVID-19 Vaccines
A recently released report from the Food and Drug Administration (FDA) has revealed that there are no conclusive links between coronavirus vaccines and fatalities in children. This report surfaced confidentially last week, providing reassurance about vaccine safety amidst ongoing debates.
Disputed Claims of Child Deaths Linked to Vaccines
The report’s findings contrast sharply with claims made six months ago by former FDA vaccine chief Dr. Vinay Prasad, who alleged that the agency had identified at least 10 vaccine-related child deaths, though he provided no supporting evidence. Dr. Prasad’s statements sparked discussions about potential changes to the FDA’s vaccine review processes. After stepping down from the agency in April, his tenure was scrutinized due to delays in approving treatments for rare diseases.
Expert Insights on Vaccine Safety
Dr. Jesse Goodman, a former chief scientist at the FDA and an infectious disease expert at Georgetown University Medical Center, emphasized that the current evidence does not support claims of high numbers of vaccine-related deaths among children. His analysis of the findings reinforces the FDA’s stance on vaccine safety.
Senator Johnson’s Inquiry and FDA Transparency
The recent FDA report was brought to light through a letter sent by Senator Ron Johnson (R-Wis.) to Health and Human Services Secretary Robert F. Kennedy Jr., underscoring the need for transparency regarding COVID-19 vaccine safety. HHS officials have since confirmed the document’s validity.
Methodology and Findings of the FDA’s Analysis
In its December 5 analysis, the FDA reviewed 96 pediatric death reports filed with the Vaccine Adverse Event Reporting System (VAERS) up to August 14, 2025. VAERS allows any individual, including healthcare professionals and caregivers, to report adverse health events post-vaccination. However, the system’s data has inherent limitations, which the FDA acknowledged in its report. It is not always possible to ascertain whether a vaccine caused a reported adverse event.
Classification of Deaths and Underlying Causes
After examining the cases, the FDA concluded that none of the deaths were definitively related to COVID-19 vaccinations. This conclusion directly contradicts Dr. Prasad’s interpretation, which suggested a causal relationship. The agency classified five deaths as “probable” and two as “possible,” yet clarified that these classifications do not imply causation; alternative explanations remain plausible and must be investigated.
Demographics and Associated Risks
The report indicated that among the deceased children—five boys and two girls—had an average age of 13. Most cases were associated with myocarditis, a rare type of heart inflammation linked to COVID-19 vaccines, particularly affecting teenage boys and young men. In June, prior to Dr. Prasad’s claims, the FDA had instructed Pfizer and Moderna to update their vaccine labels to include myocarditis risk, a condition flagged since its first identification in 2021.
Possible Risks and Considerations
Dr. Ofer Levy, who leads the Precision Vaccines Program at Boston Children’s Hospital, stated that the likelihood of developing myocarditis from COVID-19 vaccinations stands at about 100 cases per million doses. He stressed that infections, particularly from viruses such as the novel coronavirus, herpesvirus type 6, and parvovirus B19, are the primary instigators of this heart inflammation. While mild cases may resolve with rest and monitoring, severe instances require hospitalization.
